Study identifies barriers and enablers of diabetic retinopathy screening

July 12, 2018, City University London

A new study, conducted as part of a NIHR-funded project on diabetic retinopathy screening, has identified important barriers, and enablers, associated with screening attendance.

Led by researchers at City, University of London in collaboration with eight other universities, the study findings could be used to design interventions to increase screening attendance, helping to improve early diagnosis of the leading cause of vision loss amongst working-age adults in the Western world.

The four key recommendations based on the findings are: (1) to reduce inconvenience to people with diabetes; (2) to increase awareness of the importance of screening; (3) to increase a sense of comfort and support; and (4) to improve message content.

The findings are important, as despite evidence supporting the effectiveness of screening (DRS) in reducing the risk of sight loss, attendance for screening is still consistently below recommended levels. In the UK, 20% of those offered screening do not attend, and as a result, the findings could help increase attendance for particular ethnic and social groups with low attendance rates. The research is published in the journal Diabetic Medicine.

Diabetic is caused by high blood sugar levels damaging the small blood vessels at the back of the eye (retina). Screening for diabetic retinopathy to detect and treat early signs can prevent sight loss, but the success of these interventions is dependent on early detection and timely referral for treatment.

The duration of diabetes is the strongest predictor for the development and progression of retinopathy, but it usually takes several years for diabetic retinopathy to reach a stage where it could threaten sight. However, within 20 years of diagnosis, nearly all patients with type 1 diabetes and more than 60 per cent of patients with type 2 have retinopathy.

It has been estimated that globally approximately 93 million individuals may have some form of diabetic retinopathy, with 28 million suffering from the sight-threatening end points of the disease. This also as a significant economic cost associated with the condition.

To identify the barriers and enablers associated with screening – in particular those most likely influence attendance—the researchers carried out a systematic review of the literature, and coded each of the 69 studies found into six different domains representing categories of theoretical barriers/enablers proposed to mediate behaviour change.

The combined content and framework analysis identified six Theoretical Domains Framework domains as the most influential factors in screening attendance: (1) environmental context and resources; (2) social influences; (3) knowledge; (4) memory, attention and decision processes; (5) beliefs about consequences; and (6) emotions.

The authors suggest that interventions that target these domains may be more likely to increase screening attendance.

A recent output from the same project showed that interventions that specifically targeting patients, healthcare professionals or the health system resulted in a 12 per cent overall increase in retinopathy screening attendance compared to usual care and that they also were good value for money.

Speaking about the study, Professor John Lawrenson, lead author of the Cochrane review and a Professor of Clinical Visual Science at City, University of London, said:

"Our new study has identified a number of common barriers, and also enablers, that affect screening for diabetic retinopathy. Based on our research, we suggest that number of recommendations, such as increase awareness of the importance of screening and also improved message content, which could be used to inform interventions which ultimately could improve overall screening attendance and ensure that people with the condition get the treatment and support as early as possible.

"Combined with other findings from our recent NIHR project, which found that interventions aimed at patients, healthcare professionals and healthcare system were effective at improving overall attendance by 12 per cent, we hope that this will lead to policy changes which will ultimately help patients avoid diabetic retinopathy, and prevent what is globally the leading cause of vision loss amongst working-age adults in the Western word."

Explore further: Interventions increase attendance for diabetic retinopathy screening, says study

Related Stories

Interventions increase attendance for diabetic retinopathy screening, says study

January 31, 2018
Targeted interventions can significantly improve screening for diabetic retinopathy, a complication of diabetes and the leading cause of vision loss amongst working-age adults in the Western word, according to a new Cochrane ...

Barriers for diabetic retinopathy screening vary

October 20, 2016
(HealthDay)—Patients and health care providers have markedly divergent perceptions of barriers to diabetic retinopathy screening, according to a study published in the Oct. 6 issue of the U.S. Centers for Disease Control ...

New screening tool can identify diabetic retinopathy

October 16, 2017
(HealthDay)—A new screening tool can adequately detect risk of diabetic retinopathy in adults with diabetes in low-income communities in Mexico, according to a study published in the October issue of Preventing Chronic ...

Study seeks to improve diabetic eye health

October 11, 2016
While diabetes is the most common cause of blindness in the working-age population in the U.S., only about 55% of lower income adults living with the disease undergo the retinal screening needed to detect and help prevent ...

Diabetic retinopathy screening for children with type 1 diabetes should start later

September 1, 2015
A new study has found that the occurrence of advanced forms of a diabetic eye disease remains low among children living with diabetes, regardless of how long they have had the disease or their ability to keep blood sugar ...

US approves artificial-intelligence device for diabetic eye problems

April 12, 2018
US regulators Wednesday approved the first device that uses artificial intelligence to detect eye damage from diabetes, allowing regular doctors to diagnose the condition without interpreting any data or images.

Recommended for you

Outbreak of preventable eye infection in contact lens wearers

September 21, 2018
A new outbreak of a rare but preventable eye infection that can cause blindness, has been identified in contact lens wearers in a new study led by UCL and Moorfields Eye Hospital researchers.

Newly formed blood vessels may contribute to eye disease

September 14, 2018
Newly formed blood vessels may be cracks in the barrier between the bloodstream and the eye, according to a Northwestern Medicine study published in the Proceedings of the National Academy of Sciences.

Eye disease can cause blindness, and it's on the rise

August 29, 2018
A new study into recent cases of ocular syphilis warns increasing numbers of people are at risk of permanent damage to their vision.

INSiGHT identifies unique retinal regulatory genes

August 28, 2018
Vision begins in the retina, a light-sensing neural network in the eye that is critical for our ability observe the world around us. Researches at Baylor College of Medicine, Texas Children's Hospital and the Hospital for ...

Alzheimer's one day may be predicted during eye exam

August 23, 2018
It may be possible in the future to screen patients for Alzheimer's disease using an eye exam.

Researchers find potential new gene therapy for blinding disease

August 20, 2018
The last year has seen milestones in the gene therapy field, with FDA approvals to treat cancer and an inherited blinding disorder. New findings from a team led by University of Pennsylvania vision scientists, who have in ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.